ClinicalTrials.gg
Drug

Triheptanoin clinical trials

Also written UX007 and Dojolvi.

studies test it
28
open now
1
in phase 3
3
first study started
2009

How each study uses triheptanoin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the triheptanoin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Jun 2020 · DOJOLVI · NDA 213687 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Triheptanoin
25
C7
6
C7 oil
4
glycerol triheptanoate
2
Heptanoate
2

Brand

Dojolvi
4

Development codes

UX007
11
IND 113386
1

Studies by the year they started

28 studies that test it; most in 2014 (5)

Studies that test triheptanoin, by start year
YearStudies
20091
20111
20121
20131
20145
20154
20163
20172
20184
20201
20221
20231
20241
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
5
Phase 2
20
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 22

Ultragenyx Pharmaceutical Inc (6) · Institut National de la Santé Et de la Recherche Médicale, France (3) · Juan Pascual (3) · University of Texas Southwestern Medical Center (2) · Rigshospitalet, Denmark (2) · Jerry Vockley, MD, PhD (2) · The University of Queensland (1) · Areeg El-Gharbawy (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test triheptanoin, phase 3 first.

Studies

Open first, then newest update. How each study uses triheptanoin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 28

See all 28 studies that test triheptanoin →

Codes

What other systems call triheptanoin · ClinicalTrials.gg INT005310

  • MeSH (NLM) C531010triheptanoinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2P6O7CFW5KTRIHEPTANOINConfirmed FDA, NLM, Wikidata
  • RxNorm 1313234Confirmed FDA, Wikidata
  • Wikidata Q414576triheptanoinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166587TriheptanoinOne source FDA
  • DrugBank DB11677One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.